NeoGenomics Reports 18% Revenue Growth and Strong Gains in Adjusted EBITDA

Go back to NeoGenomics Reports 18% Revenue Growth and Strong Gains in Adjusted EBITDA
NEOGENOMICS (NASDAQ: NEO) Delayed: 17.59 +0.21 (1.21%)
Previous Close $17.38    52 Week High $9.54 
Open $17.15    52 Week Low $5.49 
Day High $17.84    P/E 439.75 
Day Low $16.95    EPS $0.04 
Volume 644,127